Mitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AML

Clinical trial NCT06621212 · RECRUITING

Trial details

NCT number

NCT06621212

Sponsor

First Affiliated Hospital of Zhejiang University

Status

RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2024-07-05

Primary completion

2026-12-31

Enrollment

72

View on ClinicalTrials.gov